Skip to content

Home
About Us
- Board of Directors
- Management Team
Technology
News/Resources
Investor Centre
Contacts

Appendix 4G and Corporate Governance Statement

29 August 2018 by Audrey Thomson

Appendix 4G and Corporate Governance Statement 2018

Categories 2018, ASX Announcements

Year End Accounts and Preliminary Final Report

Significant Immunological Outcomes in BIT225 HIV-1 Clinical Trial

© Biotron Limited 2016 ABN 60 086 399 144 Site updated 24 April 2025 Legal Notices and Privacy